secwatch.observer — SEC 8-K summary
======================================

Issuer:     CALLAN JMB INC. (CJMB)
CIK:        0002032545
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001493152-25-023445
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Callan JMB Q3 revenue $1.4M, operating loss $1.9M; expands into food sampling and India
--------------------------------------------------------------------------------

- Revenue $1.4M Q3, $4.6M YTD; operating loss $1.9M Q3, $4.5M YTD.
- Entered food sampling sector; signed preliminary agreement for oral drug delivery equipment at Texas cGMP facility.
- Formed Indian subsidiary for pharma storage; extended Chicago contract to June 2026 with $1.5M increase ($9.1M total).
- Upgraded Sentry Monitoring System to v4.0 with HTML5 for web-based temperature monitoring.
- SG&A rose to $2.4M Q3 from public listing costs; cash at $2.8M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2032545/000149315225023445/0001493152-25-023445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2032545/000149315225023445/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-023445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer